On the origin of capsids Nature.com The origin and evolution of viruses is a topic of debate; in particular, the timing and relationship of cellular and viral evolution are controversial. To identify cellular homologues of viral proteins, Krupovic and Koonin performed an analysis of ... |
Author Archives: ev1
Cook Medical, Indiana Limestone among local business recognized for longevity – The Herald-Times (subscription)
Cook Medical, Indiana Limestone Co., Cassady Electric and Bright & Williamson Insurance Agency were recognized among the 34 Indiana businesses to receive the Governors Century or Half Century Business Award this year.
Two businesses in Monroe County were recognized for their longevity and service to their employees, community and the state. Cassady Electric and Cook Medical were founded 52 and 54 years ago, respectively. In Lawrence County, Indiana Limestone Co. was recognized for 91 years of service. Brown County's Bright & Williamson Insurance Agency was recognized for its 96 years in service.
"I am thrilled to celebrate this year's honorees and their integral role in building one of the nation's best business climates," Gov. Eric Holcomb said in a press release. "Together, I'm confident we will continue to take Indiana to the next level, ensuring Indiana is the best place to start a business, grow a business and get a job."
According to a release from the Indiana Economic Development Corp., the award has recognized more than 1,400 companies from across Indiana over its 26-year history.
As Cook has grown over the years, so has our impact on the state of Indiana, said Pete Yonkman, president of Cook Medical and Cook Group, in a Cook-issued news release. But our impact goes well beyond jobs. Our renovation of historic buildings has helped revitalize entire communities, and our partnerships with universities across the state are helping pave the way for the next generation of Indiana leaders and innovators.
Founded in Bloomington in 1963, Cook Medical employs more than 7,000 workers throughout the state. The medical device manufacturer makes 16,000 products that serve 13 hospital lines across 135 countries, according to the IEDC release.
Bright & Williamson Insurance Agency, an insurance agency located in Nashville, Indiana, has served the Brown County community since 1921.
Commercial and residential electrical construction company Cassady Electric is a family-owned business that can trace its roots in Bloomington back more than half a century. The business is a certified Women's Business Enterprise, meaning owner Mae Cassady controls at least 51 percent of the company.
"I felt very honored to be nominated," Cassady said. "I guess I never thought I would leave Kentucky at 19, and 50-some odd years later, I would be doing this."
Nominated by the Bloomington Economic Development Corp., Cassady said she credited some success to Bloomington's welcoming a woman business owner. Cassady said treating her customers the way she wants to be treated has helped keep the business alive.
Indiana Limestone Co., with a headquarters in Bedford, was recognized for its 91 years since several smaller business merged to form the company in 1926.
It recognizes that we have a great legacy, stretching beyond the founding of our firm 91 years ago to the predecessor firms that were quarrying this stone back into the 19th century," Tom Quigley, Indiana Limestone Co. CEO, said in an email. "The work ethic that has been part of this company from the beginning is every bit as important as the world-class stone that has helped create the architectural landscape of America.
The limestone supplier has provided material for the Empire State Building, the National Cathedral and more than half the state capitols in the nation.
"In every major city across the country, there was an Indiana Limestone Co. sales office. Name a major place, and they had a sales office there that helped further the use of Indiana limestone," Chief Operating Officer Duffe Elkins said. "We've been quarrying stone since Lincoln was president, that's what I like to tell people."
See original here:
Cook Medical, Indiana Limestone among local business recognized for longevity - The Herald-Times (subscription)
Genetic engineering could damage export market – Stuff.co.nz
PETER MCDONALD
Last updated10:25, March 29 2017
TIM CRONSHAW/FAIRFAX NZ
Genetically engineered cows at AgResearch's Animal Containment Facility at the Ruakura Research Centre in 2009.
There seems to be some big issues appearing on the horizon for New Zealand agriculture. Two of these being our status in regard to Genetic Engineering (GE) and the realisation that on farm animal emissions will need to be addressed in the near future.
While many may think these are issues to be dealt separately some believe that the two are linked and one may fix the other.
Is our central government putting too much faith into the premise that potential GE technologies may have a significant impact on reducing animal emissions?
READ MORE:Big meat processors to face consequences of smaller sheep flock
We would be foolish to pin all our hopes on technologies that aren't even developed yet.The enormity of the issue regarding "farm emissions" will dictate that the methods employed to mitigate will have to be broader.
My greatest concern however about GE in agriculture as a nation reliant on exports, is how will we be viewed by our customers? Whether these overseas consumers of our products are informed or uniformed it doesn't really matter,what matters is what they believe. To blindly brush aside our consumer's beliefs then move forward with GE without a thorough understanding of potential in market effects would be reckless.
Could we do long term damage to our exporting base overnight with a "flick of the GE switch?"
Following on, would we then as a country be consigned to the global commodity "bargain bin"?
All the currenttalk is about elevating ourselves out of the commodity mind-set into one of value. If New Zealand wasto embrace GE my question would be, can we then go on to compete with other large producing nations, all wrestling for positions exclusively on price? These countries most likely are closer to large consuming populations and do not have the costs of compliance surrounding employment and environment.
If we decide to try to take on these competitors on cost, we will fail. The benign introduction of GE technologies into our agricultural systems may well make this decision for us in the value versus volume debate.
In 1970 one of the greatest people that you may never have heard of wasDr Norman Borlag,described as the father of the "green revolution". In his Nobel Laureate lecture on the eve of receiving his prize, he was very clear when he said in regards to global food demand:"I've only given the world a 30 year breathing space before other technologies must present themselves".
He also went on to say:"For the genetic improvement of food crops to continue at a pace sufficient to meet the needs of humankind in the future both conventional breeding and biotechnology methodologies will be needed"
Is GE part of these new technologies Dr Borlag spoke of? Most probably so.
Does New Zealand need to uptake this technology so as to feed the world? Not necessarily.
-Stuff
View original post here:
Genetic engineering could damage export market - Stuff.co.nz
Automating Biology Experiments With Legos – R & D Magazine
Elementary and secondary school students who later want to become scientists and engineers often get hands-on inspiration by using off-the-shelf kits to build and program robots. But so far its been difficult to create robotic projects to foster interest in the wet sciences biology, chemistry and medicine so called because experiments in these field often involve fluids.
Now, Stanford bioengineers and their collaborators have shown how an off-the-shelf kit can be modified to create robotic systems capable of transferring precise amounts of fluids between flasks, test tubes and experimental dishes.
By combining the Lego Mindstorms robotics kit with a cheap and easy-to-find plastic syringe, the researchers created a set of liquid-handling robots that approach the performance of the far more costly automation systems found at universities and biotech labs.
We really want kids to learn by doing, saidIngmar Riedel-Kruse, PhD, assistant professor of bioengineering.
We show that with a few relatively inexpensive parts, a little training and some imagination, students can create their own liquid-handling robots and then run experiments on it so they learn about engineering, coding and the wet sciences at the same time, he added.
A paper describing the workwas published March 21 inPLoS Biology. Riedel-Kruse is the senior author. The lead author is postdoctoral scholar Lukas Gerber.
Robots meet biology
The robots are designed to pipette fluids from and into cuvettes and multiple-well plates types of plastic containers commonly used in laboratories. Depending on the specific design, the robots can handle liquid volumes far smaller than 1 microliter, a droplet about the size of a single coarse grain of salt. Riedel-Kruse believes that these Lego designs might even be useful for specific professional or academic liquid-handling tasks that normally require robots costing many thousands of dollars.
His overarching idea is to enable students to learn the basics of robotics and the wet sciences in an integrated way. Students could learn to collaborate while also developing STEM skills, such as mechanical engineering and computer programming. (STEM stands for science, technology, engineering and mathematics.) They could also gain a deeper appreciation of the value of robots in life sciences experiments.
Riedel-Kruse said he drew inspiration from constructionism, a learning theory that advocates project-based learning in which students make tangible objects and connect different ideas and areas of knowledge and thereby construct mental models to understand the world around them. One of the leading theorists in the field was Seymour Papert, whose seminal 1980 bookMindstormswas the inspiration for the Lego Mindstorms sets.
I saw how students and teachers were already using Lego robotics in and outside school, usually to build and program moving car-type robots, and I was excited by that, he said. But I saw a vacuum for bioengineers like me. I wanted to bring this kind of constructionist, hands-on learning with robots to the life sciences.
Do it yourself
In theirPLoS Biologypaper, the team members offer step-by-step building plans and several fundamental experiments targeted to elementary, middle and high school students. They also offer experiments that students can conduct using common household consumables like food coloring, yeast or sugar. In one experiment, colored liquids with distinct salt concentrations are layered atop one another to teach about liquid density. Other tests measure whether liquids are acids, like vinegar, or bases, like baking soda, or which sugar concentration is best for yeast. Yet another experiment uses color-sensing light meters to align color-coded cuvettes.
The coding aspect of the robot is elementary, Riedel-Kruse said. A simple programming language allows students to place symbols telling the robot what to do: Start. Turn motor on. Do a loop. And so forth. The robots can be programmed and operated in different ways. In some experiments, students push buttons to actuate individual motors. In other experiments, students preprogram all motor actions to watch their experiments executed automatically.
Its kind of easy. Just define a few parameters, and the system works, he said, adding, These robots can support a range of educational experiments, and they provide a bridge between mechanical engineering, programming, life sciences and chemistry. They would be great as part of in-school and after-school STEM programs.
STEM-ready
Riedel-Kruse said these activities meet several important goals for promoting multidisciplinary STEM learning as outlined by the Next Generation Science Standards and other national initiatives. He stressed the cross-disciplinary instruction value that integrates robotics, biology, chemistry, programming and hands-on learning in a single project.
The team has co-developed these activities with high school students and a science teacher, and then tested them with elementary and middle school students over the course of several weeks of instruction. These instructions for the robots are now ready for wider dissemination to an open-access community that can expand upon the plans, capabilities and experiments for this new breed of fluid-handling robots, and they might even be suitable to support certain research applications.
We would love it if more students, do-it-yourself learners, STEM teachers and researchers would embrace this type of work, get excited and then develop additional open-source instructions and lesson plans for others to use, Riedel-Kruse said.
Originally posted here:
Automating Biology Experiments With Legos - R & D Magazine
Father of Behavioral Science and the "Margaret Mead" of Digital Culture Among Key Speakers at Investment … – Benzinga
Richard Thaler and Sherry Turkle among key national thought leaders to speak at IMCA's 2017 Annual Conference Experience.
Denver, CO (PRWEB) March 27, 2017
More than 1,600 financial service professionals will gather to learn the latest on investment and wealth management from more than 50 of the industry's foremost thought leaders at the Investment Management Consultants Association's (IMCA) 2017 Annual Conference Experience(ACE), April 30May 3, San Diego Convention Center.
General session speakers will feature internationally-known experts, including:
General sessions, super sessions, and workshops offer ACE attendees a variety of learning options based on tracks that align with their interests, including: Practice Management Strategies, Certified Investment Management Analyst (CIMA)/Investment Strategies, Certified Private Wealth Advisor/Private Wealth Advice, Business Development Strategies, Institutional Investing and the Art and Science of Wholesaling.
Topics for ACE sessions are 100 percent peer-reviewed and based on IMCA's Investment and Wealth Matrix, a foundation for all IMCA educational offerings focusing on nine key investment and wealth domains: statistical and economic fundamentals, portfolio construction and risk management, traditional and alternative investments, portfolio theory and behavioral finance, application of the investment consulting process, human dynamics, wealth management strategies, legacy planning and advising high-net-worth clients.
ACE registration is now open. Early bird registration ends March 31, 2017.
For detailed conference information, visit IMCA 2017 ACE.
Journalists interested in receiving conference credentials or using IMCA's on-site conference video studio should contact Greta Gloven, ggloven(at)imca.org, (303) 850-3079, or on Twitter @IMCA, conference hashtag #IMCA17.
###
About IMCA Established in 1985, IMCA is a nonprofit professional association and credentialing organization with individual members and certificants in 37 countries around the world. IMCA members collectively manage more than $2.5 trillion, providing investment consulting and wealth management services to individual and institutional clients. Since 1988, IMCA has offered the Certified Investment Management Analyst (CIMA), which meets international accreditation standards (ANSI/ISO 17024) for personnel certification. The CIMA certification consistently distinguishes those who meet a global standard of competency and skills in investment management from those who do not. IMCA's Certified Private Wealth Advisor (CPWA) certification is suited for wealth management professionals working with high-net-worth clients. In 2016, IMCA conferences and education hosted nearly 4,500 attendees. IMCA and Investment Management Consultants Association are registered trademarks of Investment Management Consultants Association Inc. CIMA, Certified Investment Management Analyst, CIMC, CPWA, and Certified Private Wealth Advisor are registered certification marks of Investment Management Consultants Association Inc. Investment Management Consultants Association Inc. does not discriminate in educational opportunities or any other characteristic protected by law.
For the original version on PRWeb visit: http://www.prweb.com/releases/2017/03/prweb14188357.htm
Go here to see the original:
Father of Behavioral Science and the "Margaret Mead" of Digital Culture Among Key Speakers at Investment ... - Benzinga
Even Work-Life Balance Experts Are Awful at Balancing Work and Life – New York Magazine
FACE Forward – Hour Detroit Magazine
The Latest Trends in Skin, Beauty, and Wellness Offered by Michigans Rejuvenation Experts
Published: March 28, 2017
- A D V E R T I S E M E N T -
Always at the forefront of innovation in beauty and wellness, FACE and Cutler Integrative Medicine have joined to form the ultimate state-of-the-art, award-winning rejuvenation destination. The founders, Dr. Doug Cutler and Holly Cutler, have brought their naturopathic medical and esthetic backgrounds together to merge their expertise in inside-out anti-aging.
Almost two decades ago, Holly Cutler, also known as Americas Skin Saint, rebuilt her own skin, which had been disfigured by cystic acne. Since then, she has created one of the most extensive rejuvenation clinics in the U.S., offering more than 30 laser and facial machines, liquid face-lifts, vaginal rejuvenation, and body makeovers. With her innovative Skin Management Model and her one-hour transformations, Cutler has helped thousands of people who were not satisfied elsewhere. She has been a featured expert on FOX, CBS, NBC, ABC, and The Doctors Show, and has appeared on magazine covers and in several publications. Cutler has now launched her own highly anticipated and innovative skincare product line to help people all over the country who may not be able to access the services at her clinic. She is also anticipating the publication of her new book, No Filters Needed, a guide to enjoying the best skin possible for years to come.
The wellness division, headed by Dr. Doug Cutler, a licensed naturopathic physician, finds the root cause of imbalances in the body to create overall well-being from the inside out. His state-of-the-art clinic incorporates natural elements, and air and water purification systems, and is home to one of the most advanced detoxification clinics in the country. Dr. Cutler is the only doctor in Michigan who has the most advanced training in environmental medicine and genetic polymorphisms. His specialties include integrative medicine; anti-aging medicine; botanical medicine; detoxification therapies; nutrition, mental, and neurological conditions; womens disorders; childrens health; and more.
Dr. Cutler recently launched his new ClubIV, one of the only FDA/USP-compliant IV/IM
(intravenous/intramuscular) nutrient therapy clinics in Michigan. The advanced nutrient formulas are customized to increase energy, improve sleep, optimize immune function, recover cellular homeostasis, promote healing and recovery, reduce stress and anxiety, support weight loss, and much more. There is no comparison to the superior potency of nutrients delivered via IV/IM therapy. The dose bypasses the gastrointestinal system and is delivered directly into the bloodstream, so results are fast allowing you to feel better, sooner.
Most people can benefit from IV/IM therapy. At your first visit, an evaluation is conducted to determine which combination of vitamins, minerals, and other nutrients will work best for you.
The range of therapies includes anti-aging, anti-inflammatory, antioxidant, detoxification, endocrine, hydration, metabolism, recovery, and wellness. The dedicated infusion room is relaxing and peaceful; during your IV session you may experience local warmth, an increase in energy, or a deepening sense of calm and well-being.
Dr. Cutler is a member of the American Association of Naturopathic Physicians, the Michigan Association of Naturopathic Physicians, the American College for Advancement in Medicine, and the Pediatric Association of Naturopathic Physicians, and he is the board director for the Naturopathic Academy of Environmental Medicine.
As rejuvenation experts, the team of Dr. Doug Cutler and Holly Cutler can enhance your health, improve your overall quality of life, and keep you looking youthful for years to come.
The rest is here:
FACE Forward - Hour Detroit Magazine
Scientists Are One Step Closer To An Anti-Aging Drug – Civilized
Forget the Fountain of Youth; scientists are closer than ever to creating a safe and effective anti-aging drug, its been revealed.
Through a series of experiments on mice, researchers from Harvard Medical School and the University of New South Wales School of Medicine in Australia have discovered an essential clue as to how our cells repair damaged DNA. This is important because the bodys inability to mend DNA can result in age-related deterioration, claim the scientists.
They go on to say that when humans are young, they have great amounts of the DNA-repairing protein PARP1. As we age, however, another protein called DBC1 clings to it, rendering it impossible to finish its recon work. This makes it increasingly difficult for our systems to fix broken DNA.
In their study, the researchers fed old mice a molecule called NMN. The mice metabolized it into a signalling molecule called NAD, which squeezed in between the PARP1 and DBC1 proteins and pushed them apart. The DNA-repairing protein was then able to work effectively again, just like when the mice were younger.
This restored the DNA capacity of the old mouse back to a young mouse, and also to remove the DNA damage that accumulated in the tissue, said study author David Sinclair, Ph.D.
The scientists then exposed the mice to DNA-damaging radiation. The mice that were treated with the NMN molecule didnt show the usual effects of radiation, which include changes in white blood cell counts and hemoglobin levels.
While the scientists push that the NMN treatment has only been tested in mice and that the results may be different in people, they hope to begin human trials within six months.
This is the closest we are to a safe and effective anti-aging drug thats perhaps only three to five years away from being on the market if the trials go well, Sinclair said.
The drug could one day serve as a treatment for preventing DNA damage from aging, radiation and even chemotherapy.
h/t Mens Health
See the rest here:
Scientists Are One Step Closer To An Anti-Aging Drug - Civilized
Fountain of Youth to celebrate 10th anniversary – Victoria Advocate
Victoria Advocate | Fountain of Youth to celebrate 10th anniversary Victoria Advocate Le, a physician who specializes in internal medicine, aesthetic medicine and anti-aging medicine, moved into the shopping center about 10 years ago. "It's quite a journey, and we want to celebrate the contributions our business has brought to the ... |
View original post here:
Fountain of Youth to celebrate 10th anniversary - Victoria Advocate
Life Extension and Insilico Medicine Use Artificial Intelligence to Develop Ageless – WholeFoods Magazine
Fort Lauderdale, FL Life Extension has partnered with Insilico Medicine to introduce Ageless Cell, the first supplement in its GEROPROTECT line to promote healthy aging by inhibiting cellular senescence.
Cellular senescence is a natural part of the aging process where cells no longer function optimally, affecting organ function, cellular metabolism, and the inflammation response. The accumulation of these senescent cells contributes to the process of aging. The Ageless Cell supplements inhibit the effects of cellular senescence by acting as geroprotectors, or interventions aimed to increase longevity and impede the onset of age-related diseases by targeting and inhibiting senescence-inducing pathways and inhibiting the development of senescent cells.
The partnership with Insilico Medicine allowed researchers to use deep learning algorithms to comb through hundreds of studies and thousands of data points a process that could have taken decades to identify four key anti-aging nutrients: N-Acetyl-L-Cysteine (NAC), myricetin, gamma-tocotrienol, and EGCG. These compounds target pathways that are known to contribute to or protect against the development of senescent cells.
Specifically, NAC upregulates signaling pathways that protect cells against oxidative stress, which promotes cellular senescence. It also reduces pathways that promote inflammation. Myricetin regulates a family of stress-responsive signaling molecules known to regulate aging in many tissues. It also promotes cell differentiation and self-repair. Gamma tocotrienol modulates the mevalonate pathway that controls cholesterol production, cancer promotion, and bone formation. And EGCG regulates the Wnt pathway that determines the fate of developing cells and also prevents sugar-induced damage to tissues, helping to suppress their pro-aging effects.
Clinical aging studies are extremely difficult, if not impossible, to perform at this time. Our collaboration with Insilico Medicine has allowed us to develop geroprotective formulations by using artificial intelligence to study very large data sets, said Andrew G. Swick, Ph.D., senior vice president of product development and scientific affairs for Life Extension.
Scientists found these four nutrients have various complementary and reinforcing properties to influence key anti-aging pathways and combat aging factors by modulating specific biological pathways. By rejuvenating near-senescent cells and encouraging the bodys healthy process for dealing with senescent cells, Ageless Cell turns back the clock at the cellular level, said Michael A. Smith, M.D., senior health scientist for Life Extension.
Alex Zhavoronkov, Ph.D., CEO of Insilico Medicine said, Together, these four natural compounds represent the beginning of the future anti-aging cocktails identified using artificial intelligence under expert human supervision.
Read the original here:
Life Extension and Insilico Medicine Use Artificial Intelligence to Develop Ageless - WholeFoods Magazine
Cardax Astaxanthin Compound CDX-085 Stimulates Anti-Aging … – Business Wire (press release)
HONOLULU--(BUSINESS WIRE)--Cardax, Inc. (Cardax) (OTCQB:CDXI) and the University of Hawaii (UH) announced today that Cardaxs proprietary astaxanthin compound, CDX-085, demonstrated an almost 90% increase in FOXO3 gene expression in mice (p=0.024).
This research was conducted by UH scientists Dr. Bradley Willcox, M.D., Professor and Director of Research at the Department of Geriatric Medicine, John A. Burns School of Medicine, University of Hawaii (JABSOM) and Principal Investigator of the NIH-funded Kuakini Hawaii Lifespan and Healthspan Studies, and Dr. Richard Allsopp, Ph.D., Associate Professor, Institute of Biogenesis Research at JABSOM.
Previously in humans, Dr. Willcox and colleagues discovered genetic variants of FOXO3 in humans that protect against aging (Willcox et al. Proc US Natl Acad Sci 2008).
This observation has since been replicated in >20 independent studies. At the American Heart Association Meeting in 2015, it was announced that the protective FOXO3 allele is strongly associated with reduced coronary heart disease mortality (p=0.00001) (AHA Meeting 2015) and later published in the leading gerontology journal (Willcox et al. J Gerontol Biol Med Sci 2016).
These results augment earlier findings in the C. elegans roundworm, a well-accepted model of aging, said Dr. Allsopp, where astaxanthin extended lifespan by 16-30%.
All of us have the FOXO3 gene, which protects against aging in humans, said Dr. Willcox. But about one in three persons carry a version of the FOXO3 gene that is associated with longevity. By activating the FOXO3 gene common in all humans, we can make it act like the "longevity" version. Through this research, we have shown that astaxanthin activates the FOXO3 gene.
This exciting new evidence provides yet another reason for physicians and patients to consider an astaxanthin dietary supplement such as ZanthoSyn as the foundation of an anti-aging, longevity program, said David G. Watumull, Cardax CEO.
About CDX-085
CDX-085 is the patented active ingredient of Cardaxs second generation product and like its first generation dietary supplement, ZanthoSyn, delivers astaxanthin to the blood stream with excellent absorption and purity, but in a more concentrated form, allowing higher doses per capsule and improved dosing convenience. Astaxanthin is a safe anti-inflammatory for general health that supports anti-aging and longevity.*
About FOXO3
FOXO3 is a member of the forkhead family of transcription factors. The human homolog in C. elegans, daf-16, has profound effects on longevity (Kenyon et al. A C. elegans mutant that lives twice as long as wild type. Nature 1993). Scientists led by Dr. Bradley Willcox, MD, member of the Cardax scientific advisory board, discovered a genetic variant of FOXO3 in humans that protects against aging (Willcox et al. Proc US Natl Acad Sci 2008). This observation has since been replicated in >20 independent studies. The protective FOXO3 allele (G allele) is associated with longevity with one G allele (GT genotype) doubling the odds to live to 100 and two G alleles (GG genotype) tripling the odds to live to 100. The protective FOXO3 allele is strongly associated with reduced coronary heart disease mortality (p=0.00001) (Willcox et al. AHA Meeting 2015) and the protective FOXO3 allele is strongly associated with reduced serum inflammatory markers (CRP and TNF-).
About Cardax
Cardax devotes substantially all of its efforts to developing and commercializing safe anti-inflammatory dietary supplements and drugs. Cardax is initially focusing on astaxanthin, which is a powerful and safe naturally occurring anti-inflammatory without the side effects of currently marketed anti-inflammatories. The safety and efficacy of Cardax's products have not been directly evaluated in clinical trials or confirmed by the FDA.
Safe Harbor
This release may contain certain forward-looking statements regarding our prospective performance and strategies within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and are including this statement for purposes of said safe harbor provisions. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations of our company, are generally identified by use of words anticipate, believe, estimate, expect, intend, plan, project, seek, strive, try, or future or conditional verbs such as could, may, should, will, would, or similar expressions. Our ability to predict results or the actual effects of our plans or strategies is inherently uncertain. Accordingly, actual results may differ materially from anticipated results. Some of the factors that could cause our actual results to differ from our expectations or beliefs include, without limitation, the risks discussed from time to time in our filings with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this release. Except as required by applicable law or regulation, we undertake no obligation to update these forward-looking statements to reflect events or circumstances that occur after the date on which such statements were made.
See the original post:
Cardax Astaxanthin Compound CDX-085 Stimulates Anti-Aging ... - Business Wire (press release)
Brain Resets During Sleep – Anti Aging News
Posted on March 28, 2017, 6 a.m. in Sleep Brain and Mental Performance
New research explains how synapses in the cortex expand with daytime stimulation and shrink with sleep, resetting the brain and preparing it for the next day.
The need for, and mechanisms that drive sleep have consistently puzzled scientists. However, novel work from researchers at the University of Wisconsin School of Medicine and Public Health have tested their synaptic homeostasis hypothesis (SHY) for why animals need sleep. SHY theory describes a need for sleep
This four-year study by Luisa de Vivo and her colleagues, published in Science, supported the SHY theory. The SHY theory describes changes in synapses during waking and sleeping hours. Synapses are the junctions between two neurons, the larger the synapse, the stronger these two neurons can communicate - this ease of communication is how animals learn skills and make memories. Yet in order for brains to be pliable and learn new things, the synapses must shrink so these neural pathways can be activated again. SHY theory suggests that sleep allows these synapses to shrink.
According to SHY theory, sleep provides the perfect environment for the shrinking of synapses, allowing the brain to learn new things following day. The lack of stimulation while sleeping results in reduced activity between neurons, and therefore the distance between the neurons grows smaller allowing them to be activated with a weaker stimulation. This phenomenon allows brains to make new neural connections the following day, thereby allowing new memories to form and more efficient learning.
Testing SHY theory
Lead author Luisa de Vivo, along with her fellow researchers, tested their theory by measuring the size of synapses both before and after sleep. They utilized three-dimensional scanning electron microscopy to visualize and reconstruct the mouse brain and measured nearly 7000 synapses. They specifically looked at neurons involved in motor functions and sensory perception. The team then repeated this process after the mice had slept (making sure to note how long the mice had slept), and measured the synapses again.
The researchers found that the synaptic size correlated with the amount of sleep the mice had. The longer the mice had slept, the smaller the synapses had become with a few hours sleep resulting in the reduction by ~18 percent. Interestingly, the researchers only observed this phenomenon in ~80 percent of synapses and that the largest of synapses appeared not to be susceptible to the shrinking. They hypothesize that these synapses might not follow the pattern because those synapses are associated with stable, long-term memories or skills. These results support SHYs central tenant that the function of sleep is to renormalize synapse size that increases throughout the day. The researchers theorize that the shrinking of the synapses might be related to the lack of neurotransmitters during sleep, especially noradrenaline.
Giulio Tononi, head of the research group and Chair of Sleep Medicine at the University of Wisconsin believes the relevance of this works extends beyond mice, "extrapolating from mice to humans, our findings mean that every night trillions of synapses in our cortex could get slimmer by nearly 20 percent,"
The lack of stimulation that brains receive during sleep allows specific synapses to shrink, resulting in a brain that is ready to learn and create new memories the following day. This research provides rational to the large body of work that suggests animals learn skills better following a long sleep. Important synapses and neural pathways seem immune to this process of renormalization indicating that systems have evolved to preserve important memories and skills.
Ultrastructural evidence for synaptic scaling across the wake/sleep cycle Luisa de Vivo1, Michele Bellesi1,2, William Marshall1, Eric A. Bushong3, Mark H. Ellisman3,4, Giulio Tononi1,*, Chiara Cirelli1,* Science 03 Feb 2017: Vol. 355, Issue 6324, pp. 507-510 DOI: 10.1126/science.aah5982
See original here:
Brain Resets During Sleep - Anti Aging News
Researchers develop new tool for gene delivery – ScienceBlog.com (blog)
BOSTON (January 27, 2010) Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have developed a new tool for gene therapy that significantly increases gene delivery to cells in the retina compared to other carriers and DNA alone, according to a study published in the January issue of The Journal of Gene Medicine. The tool, a peptide called PEG-POD, provides a vehicle for therapeutic genes and may help researchers develop therapies for degenerative eye disorders such as retinitis pigmentosa and age-related macular degeneration.
For the first time, we have demonstrated an efficient way to transfer DNA into cells without using a virus, currently the most common means of DNA delivery. Many non-viral vectors for gene therapy have been developed but few, if any, work in post-mitotic tissues such as the retina and brain. Identifying effective carriers like PEG-POD brings us closer to gene therapy to protect the retinal cells from degeneration, said senior author Rajendra Kumar-Singh, PhD, associate professor of ophthalmology and adjunct associate professor of neuroscience at Tufts University School of Medicine (TUSM) and member of the genetics; neuroscience; and cell, molecular, and developmental biology program faculties at the Sackler School of Graduate Biomedical Sciences at Tufts.
Safe and effective delivery of therapeutic genes has been a major obstacle in gene therapy research. Deactivated viruses have frequently been used, but concerns about the safety of this method have left scientists seeking new ways to get therapeutic genes into cells.
We think the level of gene expression seen with PEG-POD may be enough to protect the retina from degeneration, slowing the progression of eye disorders and we have preliminary evidence that this is indeed the case, said co-author Siobhan Cashman, PhD, research assistant professor in the department of ophthalmology at TUSM and member of Kumar-Singhs lab.
What makes PEG-POD especially promising is that it will likely have applications beyond the retina. Because PEG-POD protects DNA from damage in the bloodstream, it may pave the way for gene therapy treatments that can be administered through an IV and directed to many other parts of the body, said Kumar-Singh.
Kumar-Singh and colleagues used an in vivo model to compare the effectiveness of PEG-POD with two other carriers (PEG-TAT and PEG-CK30) and a control (injections of DNA alone).
Gene expression in specimens injected with PEG-POD was 215 times greater than the control. While all three carriers delivered DNA to the retinal cells, PEG-POD was by far the most effective, said first author Sarah Parker Read, an MD/PhD candidate at TUSM and Sackler and member of Kumar-Singhs lab.
Age-related macular degeneration, which results in a loss of sharp, central vision, is the number one cause of vision loss in Americans age 60 and older. Retinitis pigmentosa, an inherited condition resulting in retinal damage, affects approximately 1 in 4,000 individuals in the United States.
This study was supported by grants from the National Eye Institute of the National Institutes of Health, the Foundation for Fighting Blindness, The Ellison Foundation, The Virginia B. Smith Trust, the Lions Eye Foundation, and Research to Prevent Blindness. Sarah Parker Read is part of the Sackler/TUSM Medical Scientist Training Program, which is funded by the National Institute of General Medical Sciences, part of the National Institutes of Health.
Read SP, Cashman SM, Kumar-Singh R. The Journal of Gene Medicine. 2010 (January). 12(1): 86-96. A poly(ethylene) glycolylated peptide for ocular delivery compacts DNA into nanoparticles for gene delivery to post-mitotic tissues in vivo. Doi: 10.1002/jgm.1415
About Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences
Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts University are international leaders in innovative medical education and advanced research. The School of Medicine and the Sackler School are renowned for excellence in education in general medicine, biomedical sciences, special combined degree programs in business, health management, public health, bioengineering and international relations, as well as basic and clinical research at the cellular and molecular level. Ranked among the top in the nation, the School of Medicine is affiliated with six major teaching hospitals and more than 30 health care facilities. Tufts University School of Medicine and the Sackler School undertake research that is consistently rated among the highest in the nation for its impact on the advancement of medical science.
If you are a member of the media interested in learning more about this topic, or speaking with a faculty member at the Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences, or another Tufts health sciences researcher, please contact Siobhan Gallagher at 617-636-6586 or, for this study, Lindsay Peterson at 617-636-2789.
See the article here:
Researchers develop new tool for gene delivery - ScienceBlog.com (blog)
Chemistry Club to host ‘Star Wars’ theme demo night – DeKalb Daily Chronicle
On Friday at a university not so far away Chem Wars!
Northern Illinois Universitys Chemistry Club invites the public to its annual Spring Chemistry Demo Night at 6:30 p.m Friday in Cole Hall room 100.
This year, the Chemistry Club will put on Chem Wars, a show that will feature a number of thrilling experiments that could have been used by the big film studios in Hollywood to create the special effects in the science fiction franchises we all love and cherish.
We certainly hope that the Star Wars theme draws lots of people to come to the show," Chemistry Club President Marina Galluzzo said in a news release. "However, I am confident that when they leave they will not only better understand the chemical concepts behind these experiments but also appreciate the love of chemistry that all volunteers participating in the show share.
Faculty members helping with this years demo include Tim Hagen, Lee Sunderlin, Chong Zheng, Tim Perkins and the Chemistry Clubs faculty adviser, Oliver Hofstetter.
The annual Chem Demo really is the highlight of the year when it comes to presenting ourselves and reaching out to the community. It is an exciting opportunity to demonstrate that science is fun and that scientists are just people like you and me, Hofstetter said in the release.
While the night will include some crowd favorites from previous years, such as the liquid nitrogen bomb and ping-pong madness, the Chem Club also will serve freshly prepared ice cream at the end of the performance.
Expect bright flashes of light and intermittent periods of low light and/or darkness during the event.
Free parking will be available in the NIU Parking Deck starting at 5 p.m., except for reserved and handicapped spaces.
For information about the Chemistry Demo, email Marina Galluzzo at mgalluzzo@niu.edu.
For information about the Chemistry Club, email Hofstetter at ohofst@niu.edu.
Original post:
Chemistry Club to host 'Star Wars' theme demo night - DeKalb Daily Chronicle
Green chemistry is key to reducing waste and improving sustainablity – EconoTimes
The development and evolution of the chemical industry is directly responsible for many of the technological advancements that have emerged since the late 19th century.
However, it was not until the 1980s that the environment became a priority for the chemical industry. This was prompted largely by stricter environmental regulations and a need to address the sectors poor reputation, particularly due to pollution and industrial accidents.
But the industry is now rapidly improving, and this changing mindset has provided the backdrop for the emergence of green chemistry.
What is green chemistry?
Sustainability is becoming increasingly important in almost every industry and chemistry is no different.
Green chemistry aims to minimise the environmental impact of the chemical industry. This includes shifting away from oil to renewable sources where possible.
Green chemistry also prioritises safety, improving energy efficiency and, most importantly, minimising (and ideally) eliminating toxic waste from the very beginning.
Important examples of green chemistry include: phasing out the use of chlorofluorocarbons (CFCs) in refrigerants, which have played a role in creating the ozone hole; developing more efficient ways of making pharmaceuticals, including the well-known painkiller ibuprofen and chemotherapy drug Taxol; and developing cheaper, more efficient solar cells.
The need to adapt
Making chemical compounds, particularly organic molecules (composed predominantly of carbon and hydrogen atoms), is the basis of vast multinational industries from perfumes to plastics, farming to fabric, and dyes to drugs.
In a perfect world, these would be prepared from inexpensive, renewable sources in one practical, efficient, safe and environmentally benign chemical reaction. Unfortunately, with the exception of the chemical processes found in nature, the majority of chemical processes are not completely efficient, require multiple reaction steps and generate hazardous byproducts.
While in the past traditional waste management strategies focused only on the disposal of toxic byproducts, today efforts have shifted to eliminating waste from the outset by making chemical reactions more efficient.
This adjustment has, in part, led to the advent of more sophisticated and effective catalytic reactions, which reduce the amount of waste. The 2001 Chemistry Nobel Laureate Ryoji Noyori stressed that catalytic processes represent the only methods that offer the rational means of producing useful compounds in an economical, energy-saving and environmentally benign way.
A secret to cleaner chemistry
Catalysts are substances that accelerate reactions, typically by enabling chemical bonds to be broken and/or formed without being consumed in the process. Not only do they speed up reactions, but they can also facilitate chemical transformations that might not otherwise occur.
In principle, only a very small quantity of a catalyst is needed to generate copious amounts of a product, with reduced levels of waste.
The development of new catalytic reactions is one particularly important area of green chemistry. As well as being more environmentally friendly, these processes are also typically more cost effective.
Catalysts take many forms, including biological enzymes, small organic molecules, metals, and particles that provide a better surface for reactions to take place. Roughly 90% of industrial chemical processes use catalysts and at least 15 Nobel Prizes have been awarded for catalysis research. This represents a tremendously important and active area of both fundamental and applied research.
Whats the outlook?
In the past 20 years since green chemistry was established, there have been tremendous advances in the industry. Nevertheless, there remains considerable room for improvement.
The chemical industry faces a number of significant challenges, from reducing its dependence on fossil fuels to playing its part in addressing climate change more generally.
Specific challenges include: capturing and fixing carbon dioxide and other greenhouse gases; developing a greater range of biodegradable plastics; reducing the high levels of waste in pharmaceutical drug manufacture; and improving the efficiency of water-splitting employing visible light photocatalysts.
History suggests that society can develop creative solutions to complex, intractable problems. However, success will most likely require a concerted approach across all areas of science, strong leadership, and a willingness to strategically invest in human capital and value fundamental research.
Alex Bissember received a 2015 Green Chemistry for Life Grant from PhosAgro/UNESCO/IUPAC.
Human Life Could Be Extended Indefinitely, Study Suggests
Goosebumps, tears and tenderness: what it means to be moved
Are over-the-counter painkillers a waste of money?
Does an anomaly in the Earth's magnetic field portend a coming pole reversal?
Immunotherapy: Training the body to fight cancer
Do vegetarians live longer? Probably, but not because they're vegetarian
Could a contraceptive app be as good as the pill?
Some scientific explanations for alien abduction that aren't so out of this world
Society actually does want policies that benefit future generations
Six cosmic catastrophes that could wipe out life on Earth
Big Pharma Starts Using Cannabis For Making Drugs In Earnest
Do you need to worry if your baby has a flat head?
Continued here:
Green chemistry is key to reducing waste and improving sustainablity - EconoTimes
GFR clears UF chemistry building of potentially explosive material – The Independent Florida Alligator
The Chemistry Lab Building was cleared for a chemical leak after a student discovered an open container with a potentially explosive liquid Saturday afternoon, officials said.
Steven Locicero, a UF chemistry graduate student, was working in a lab Saturday afternoon when he saw a damaged container of trichlorosilane, a chemical that could explode if exposed to water. He said he was concerned the exposed chemical could be a danger and reported the chemical at about 5:20 p.m.
I just wanted to be sure it was safe, the 28-year-old said.
University Police shut down Buckman Drive for more than an hour until 6:45 p.m. and blocked off foot traffic near the building.
Lt. Kristy Sasser said UPD assisted Gainesville Fire Rescue and evacuated the lab building.
GFR District Chief Joseph Hillhouse said Locicero placed the container in an over-pack container, which would block any leaks, before he evacuated the building.
(The chemical) doesnt play well with others, and we have to be safe about this, Hillhouse said.
The hazardous materials team went into the building and used air monitoring devices to see if the chemical was airborne but did not detect anything, Hillhouse said. He said the container could have erupted at any time, and the chemical may have already dissipated.
The lab where the chemical is found is used to make solid materials, Locicero said.
Hillhouse said the chemical no longer presents a hazard.
Contact Meryl Kornfield at [emailprotected] and follow her on Twitter at @MerylKornfield
See the article here:
GFR clears UF chemistry building of potentially explosive material - The Independent Florida Alligator
Why Cellect Biotechnology Stock Is Skyrocketing Today – Motley Fool
What happened
Cellect Biotechnology (NASDAQ:APOP), an Israeli-based stem-cell company, today announced the first successful stem cell transplant procedure using its ApoGraft technology in a combined phase 1/2 clinical trial in a blood cancer patient, causing its shares to rise by as much as 115%. The company's stock has since cooled off, but is still up by 80% as of 3:00 p.m. EDT.
Image source: Getty Images.
Even though stem cell transplants can be a curative treatment for many blood disorders and blood-related cancers, they tend to be a treatment of last resort because of their life-threatening side effects, such as graft-versus-host disease (GvHD). So, if Cellect's ApoGraft technology turns out to be a viable workaround, it would be a major advancement in the field, and potentially an extremely lucrative product for the company.
While Cellect's announcement is indeed exciting, its stock still isn't a great long-term bet. Cellect exited 2016 with a paltry $8 million in cash andApoGraft is probably five to six years away from reaching the market. This current trial, after all, is simply a safety and proof-of-concept study that's not designed to provide a basis for a regulatory approval.
In addition, Bellicum Pharmaceuticals'adjunct T-cell therapy BPX-501 could reach the European market as one possible solution to the GvHD problem in blood cancer patients by early 2019, and in the U.S. by perhaps 2020. In other words, Bellicum has a significant head start on Cellect, which may diminish the commercial prospects ofApoGraft moving forward.
George Budwell has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Go here to see the original:
Why Cellect Biotechnology Stock Is Skyrocketing Today - Motley Fool
Anatomy Of A Decision Series Highlights Skills Necessary To Climb To The Top Of The Corporate Ladder – Benzinga
GLG recently produced a series of videos that include interviews with a number of business leaders who have different backgrounds in the business world. GLG, the worlds leading membership network for professional learning, focused its Anatomy of a Decision series on the decision-making process that these leaders used to make some of the most difficult choices of their careers.
Each of the participants in the video series offered advice about how future leaders should approach critical decisions. Several of the participants also discussed ways they wish they had done things differently throughout their careers as well. Heres a rundown of some of the highlights from the five-part series.
For former Pfizer Inc. (NYSE: PFE) CEO Jeff Kindler, the key to his business success was an open mind.
I started saying I should be open to whatever comes along, Kindler said. And that led me down all kinds of different paths I never would have predicted.
Former New York Times executive editor Jill Abramson said preparation and confidence go a long way in the business world.
When you have to confront powerful people about unpleasant things that they dont want to talk about like their personal finances or their campaign finances, you develop a kind of calm steadiness that allows you not to get horribly nervous, Abramson said.
Pamela Thomas-Graham, former Credit Suisse Group AG (ADR) (NYSE: CS)board member, CEO of CNBC and the first ever African-American partner at McKinsey & Co., had some advice for anyone who is subjected to discrimination in the workplace. She said anger is often not constructive, but direct, open dialogue can be.
You can be angry and you can be frustrated, but if you really want to change peoples behavior you have to meet them where they are, she said.
Jeffrey Brenzel, dean of undergraduate admissions at Yale, said companies often underestimate the importance of the hiring process.
Its not who you fire, its who you hire that is going to make the difference between success and failure for your company, Brenzel said. And how those decisions are made and whos making them and what the process is for making those decisions I think could not conceivably be more critical.
Jake Sullivan, a former advisor to former President Barack Obama, discussed the importance of removing irrational emotions from his decision-making process when discussing the Iranian nuclear deal with the president.
Being able to make that decision to recommend to the president that we go ahead and do this deal required stepping back from the anxiety, the emotion, the nerve-wracking idea that maybe we were going to screw this thing up and actually systematically running a cost benefit analysis, he said.
Collectively, these five leaders have decades of experience at the highest level of the business world. Despite the fact that all of them have unique backgrounds and areas of expertise, the themes of adaptability, preparation, discipline, respect, and critical thinking were common among their discussions. In order to have a chance at reaching the pinnacle of success in any field, young entrepreneurs and aspiring executives should focus on honing these universal skills on a daily basis.
Related Links:
Anatomy Of A Decision, Part 1: The C-Suite
Anatomy Of A Decision, Part 2: The Newsroom
Anatomy Of A Decision, Part 3: Minorities In The Boardroom
Anatomy of a Decision, Part 4: The Admissions Office
Anatomy Of A Decision, Part 5: The West Wing
Posted-In: Anatomy of a Decision Barack Obama GLGNews Education Media Interview General Best of Benzinga
2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Excerpt from:
Anatomy Of A Decision Series Highlights Skills Necessary To Climb To The Top Of The Corporate Ladder - Benzinga
Is it Really High Blood Pressure? – Anti Aging News
Posted on March 27, 2017, 6 a.m. in Cardio-Vascular Diagnostics
More than half of family doctors in Canada are still using manual devices, a dated technology that often leads to misdiagnosis.
A study by researchers at the University of Montreal Hospital Research Centre (CRCHUM) reports that over half of the Canadian family doctors are still making use of manual devices to measure blood pressure, which is a dated technology. Using a manual device to measure blood pressure often leads to misdiagnosis. Approximately 20% of those receiving treatment for hypertension don't actually have it and do not need medication.
Automatic electronic devices, called oscillometric devices, are available and are recommended by the Guidelines of the Canadian Hypertension Education Program (CHEP) as preferable to manual measurement.
However, in the spring of 2016, the team that conducted the survey among the Canadian family doctors found that 52% of the 769 who responded stated that they made use of a manual tensiometer to measure patients' blood pressure, and only 43% used an automatic device.
The lead author of the study, Janusz Kaczorowski, is a medical sociologist, a CRCHUM researcher, and a professor in the Department of Family and Emergency Medicine.
Manual measurement is acceptable if it is done properly, but that is not always the case. Kaczorowski stated that clinicians should use automatic devices because they are more precise and take several measurements. Automated measurement has an advantage because it eliminates white-coat syndrome, which is an artificially high blood pressure reading that is a result of being in a doctor's office.
To take blood pressure properly, a 12- to 15-minute period is required with the patient being left alone in a room while the measurement is taken. That is difficult because the average visit to a family doctor lasts only 10 minutes.
Blood pressure is the pressure that the blood exerts on the walls of arteries. Measured in an artery in the arm, blood pressure has two measurements: systolic as the heart contracts and diastolic as the heart relaxes. Normal pressure has the systolic pressure at below 140 mmHg and the diastolic pressure at below 90 mmHg. Above those numbers, a person is said to have high blood pressure or hypertension.
In Canada, one of every five adults suffers from hypertension, which is the greatest global risk factor for disability and death. Healthcare costs due to hypertension were evaluated at over $13 billion in 2010. Kaczorowski says that if blood pressure was measured incorrectly, there are considerable financial implications as well as possible side effects, which could be avoided.
The CHEP Guidelines state that modification of health-related behaviors is an efficient way of treating and preventing high blood pressure and reducing the cardiovascular disease risk. It is possible to lower one's blood pressure with a healthy diet, reduced intake of sodium, regular physical activity, moderate consumption of alcohol, tobacco product avoidance, and stress management.
See original here:
Is it Really High Blood Pressure? - Anti Aging News
Life Extension and Insilico Medicine Use Artificial Intelligence to Develop Ageless Cell – WholeFoods Magazine
Fort Lauderdale, FL Life Extension has partnered with Insilico Medicine to introduce Ageless Cell, the first supplement in its GEROPROTECT line to promote healthy aging by inhibiting cellular senescence.
Cellular senescence is a natural part of the aging process where cells no longer function optimally, affecting organ function, cellular metabolism, and the inflammation response. The accumulation of these senescent cells contributes to the process of aging. The Ageless Cell supplements inhibit the effects of cellular senescence by acting as geroprotectors, or interventions aimed to increase longevity and impede the onset of age-related diseases by targeting and inhibiting senescence-inducing pathways and inhibiting the development of senescent cells.
The partnership with Insilico Medicine allowed researchers to use deep learning algorithms to comb through hundreds of studies and thousands of data points a process that could have taken decades to identify four key anti-aging nutrients: N-Acetyl-L-Cysteine (NAC), myricetin, gamma-tocotrienol, and EGCG. These compounds target pathways that are known to contribute to or protect against the development of senescent cells.
Specifically, NAC upregulates signaling pathways that protect cells against oxidative stress, which promotes cellular senescence. It also reduces pathways that promote inflammation. Myricetin regulates a family of stress-responsive signaling molecules known to regulate aging in many tissues. It also promotes cell differentiation and self-repair. Gamma tocotrienol modulates the mevalonate pathway that controls cholesterol production, cancer promotion, and bone formation. And EGCG regulates the Wnt pathway that determines the fate of developing cells and also prevents sugar-induced damage to tissues, helping to suppress their pro-aging effects.
Clinical aging studies are extremely difficult, if not impossible, to perform at this time. Our collaboration with Insilico Medicine has allowed us to develop geroprotective formulations by using artificial intelligence to study very large data sets, said Andrew G. Swick, Ph.D., senior vice president of product development and scientific affairs for Life Extension.
Scientists found these four nutrients have various complementary and reinforcing properties to influence key anti-aging pathways and combat aging factors by modulating specific biological pathways. By rejuvenating near-senescent cells and encouraging the bodys healthy process for dealing with senescent cells, Ageless Cell turns back the clock at the cellular level, said Michael A. Smith, M.D., senior health scientist for Life Extension.
Alex Zhavoronkov, Ph.D., CEO of Insilico Medicine said, Together, these four natural compounds represent the beginning of the future anti-aging cocktails identified using artificial intelligence under expert human supervision.
Go here to see the original:
Life Extension and Insilico Medicine Use Artificial Intelligence to Develop Ageless Cell - WholeFoods Magazine